Superluminal Medicines Inc.

📍 Boston, United States👥 15 employees💰 Last funded Aug 2023
Biotechnology Research🌐 superluminalrx.com
Website LinkedIn
Superluminal Medicines is a Boston-based generative biology and chemistry company developing a differentiated pipeline and revolutionizing the speed and accuracy of how medicine is created. Our platform creates candidate-ready compounds with unprecedented speed using a comprehensive combination of deep biology and chemistry expertise, machine learning, and proprietary big data infrastructure. The predict-design-test architecture accurately models protein shapes and designs highly selective compounds to target the precise structural change for therapeutic effect. Our discovery engine is powered by an industry-leading, pharmacokinetic and toxicology in silico prediction capability. With a lead program candidate expected in the near term, our proprietary pipeline validates our platform with initial programs focused on high-value GPCR targets. We’re pleased to be backed by a strong network of investors including RA Capital Management, Insight Partners, NVIDIA and Gaingels.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Superluminal Medicines Inc.?
Superluminal Medicines Inc. has 1 investors on record on gritt.io.
When did Superluminal Medicines Inc. last raise funding?
The most recent investment in Superluminal Medicines Inc. recorded on gritt.io was in August 2023.
What industry is Superluminal Medicines Inc. in?
Superluminal Medicines Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Superluminal Medicines Inc. based?
Superluminal Medicines Inc. is headquartered in Boston, United States.